Navigation Links
ShelfX Releases A Fridge That Knows What You Took
Date:4/26/2012

ns to its shelves; and through wireless communication, the Vending Fridge updates accounts and instantly automates billing. 

This award-winning Vending Fridge is now available for sale at $599 USD. For skilled technicians and do-it-yourself owners, the ShelfX Vending Fridge kit is also available for $299 USD. Start cashing in on this revolutionary new vending technology; reserve your Vending Fridge today at shop.shelfx.com. 

About ShelfX
ShelfX is revolutionising the checkout process by eliminating lines at checkout counters and enhancing the shopping experience for consumers worldwide. ShelfX is a pioneer in RFID and NFC-enabled self-checkout and inventory management systems. ShelfX offers a self-checkout retail platform for grocers, sports stadiums, pharmacies, airport kiosks, and more and the award-winning Vending Fridge for all businesses wanting to cash in on the convenience of offering refrigerated products, with no-hassle automated billing. ShelfX systems include ShelfX Smart Shelves, an advanced and distributed application platform, ShelfX RFID Cards and Kiosks and the ShelfX Mobile App. For more information, visit shelfx.com

Media Contact: Ran Margalit ShelfX, Inc, 8554743539, ran@shelfx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ShelfX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015  Eli Lilly and Company (NYSE: LLY ) ... tender offer for up to $1.6 billion aggregate principal amount ... of notes who tendered, and did not validly withdraw, their ... City time, on May 27, 2015 (the early ... are eligible to receive the total consideration. The total consideration ...
(Date:5/28/2015)... May 28, 2015 Zimmer Holdings, Inc. (NYSE ... finalized agreements with buyers to divest in ... Knee System assets, Biomet Discovery® Elbow System assets and ... furtherance of Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... to work constructively with the Bureau of Competition Staff ...
(Date:5/28/2015)... , May 28, 2015 /PRNewswire/ - ESSA Pharma Inc. ... for the second quarter and three and six months ended ... Canadian dollars and in accordance with International Financial Reporting Standards ... recorded a net loss of $5.9 million ($0.35 per common ... compared to a net loss of $0.4 million ($0.03 per ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 8, 2011 /PRNewswire-Asia/ -- China Medicine Corporation (Other ... leading manufacturer, developer and distributor of Western pharmaceuticals, ... in the People,s Republic of China, today announced ... China Medicine Corporation, after consultation with and upon ...
... Steve Beshear announced yesterday that most of Kentucky,s Medicaid ... state $375 million. In modernizing the state,s Medicaid pharmacy ... by pharmacy benefit managers (PBMs) to lower prescription drug ... said. "Governor Beshear has done the right ...
Cached Medicine Technology:China Medicine Corporation to Restate Financial Statements for 2006 and 2007 2China Medicine Corporation to Restate Financial Statements for 2006 and 2007 3Modernizing Medicaid Rx with 'Innovative' PBM Tools Will Help Kentucky Save $375 Million 2
(Date:5/28/2015)... 2015 External Counterpulsation (EECP/ECP) has been ... the United States. There are a growing number of ... experience symptoms of angina and these patients are often ... bypass surgery. , “No option” patients are a sizable ... disease that is considered unacceptable for heart stent or ...
(Date:5/28/2015)... Cosmetic Town Journal is a national ... alike. You can find information on a variety of ... Readers can directly connect to the doctor of their ... ground up. , The continued addition of doctors and ... grow and getting it closer to becoming an all ...
(Date:5/28/2015)... Today the National Resident Matching Program (NRMP®) released ... Residency Match®. A record-number 30,212 positions were placed ... matching algorithm was processed. Of the 1,306 positions ... Supplemental Offer and Acceptance Program® (SOAP®) leading up to ... outcome of the 2015 Main Residency Match. A record ...
(Date:5/28/2015)... Sierra Madre, CA (PRWEB) May 28, 2015 ... providing superior outpatient wound center management for a decade with ... a partnership was formed between USC and Wound Care Advantage ... team was recognized for a drop in the ... percent. , Wound healing is a complex undertaking that ...
(Date:5/28/2015)... The partners of Urgent Care of ... Dr. Alicia Almendral as their chief provider for advanced ... the newly opened facility’s plan to offer all of ... , Dr. Almendral is a board certified physician who ... cosmetic enhancement techniques. Her areas of expertise include Botox, ...
Breaking Medicine News(10 mins):Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:New York Cosmetic Doctors Now in Cosmetic Town 2Health News:New York Cosmetic Doctors Now in Cosmetic Town 3Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2
... , , HARRISBURG, Pa., July ... received free dental care, valued at nearly $160,000, in the ... United Concordia Dental. , , ... provide free preventive services to those who cannot afford dental ...
... , INDIANAPOLIS, July 23 Today, ... that the U.S. Food and Drug Administration (FDA) has approved ... origin) injection] to treat osteoporosis associated with sustained, systemic glucocorticoid ... Glucocorticoid therapy is the most common cause of secondary osteoporosis, ...
... Cancer stem-like cells have been implicated in the ... at Cedars-Sinai Medical Center,s Maxine Dunitz Neurosurgical Institute have ... these "mother" cells to generate new tumors in laboratory ... a possible strategy in the fight against malignant and ...
... , , , , ... Program (NCDP), a program of Novo Nordisk, and several member associations today ... and treatment of diabetes, one of the nation,s most pervasive and costly ... , In an open letter to the President and ...
... , , SAN DIEGO, ... ) today announced that it has priced an underwritten public ... price of $7.50 per share. Net proceeds, after estimated underwriting ... million. Orexigen has granted the underwriter a 30-day option to ...
... 23 At the 2009 American Association of Physicists ... California, Elekta will demonstrate how the company,s comprehensive VMAT ... care with precision and ease. , , ... radiation treatments, Elekta booth 423 will highlight treatment planning ...
Cached Medicine News:Health News:More than 1,000 Underinsured and Uninsured Individuals Receive Free Dental Care 2Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 2Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 3Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 4Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 5Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 6Health News:Study provides documentation that tumor 'stem-like cells' exist in benign tumors 2Health News:Study provides documentation that tumor 'stem-like cells' exist in benign tumors 3Health News:NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care 2Health News:NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care 3Health News:Orexigen(R) Therapeutics Prices Public Offering of Common Stock 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 3
Reusable shielded cable...
... A OIA MAX test delivers excellent sensitivity ... Strep with a simple, easy-to-use test that ... of performance, speed, and ease-of-use enables you ... overall costs for diagnosing and treating patients ...
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... The FLU OIA test is a ... diagnosis of Influenza A and B with ... answer in just over 15 minutes. Assay ... specimen flexibility, and performance equivalent to 14-day ...
Medicine Products: